Celularity (CELU) EBT Margin (QoQ) (2020 - 2025)
Celularity (CELU) EBT Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15,683.00 |
| Sep 30, 2025 | -917.00 |
| Jun 30, 2025 | -25,466.00 |
| Mar 31, 2025 | 175,924.00 |
| Dec 31, 2024 | -175,895.00 |
| Sep 30, 2024 | -11,960.00 |
| Jun 30, 2024 | 9,637.00 |
| Mar 31, 2024 | -22,885.00 |
| Dec 31, 2023 | 255,846.00 |
| Sep 30, 2023 | -84,753.00 |
| Jun 30, 2023 | -517.00 |
| Mar 31, 2023 | -221,894.00 |
| Dec 31, 2022 | 47,643.00 |
| Sep 30, 2022 | -115,138.00 |
| Jun 30, 2022 | 232,629.00 |
| Mar 31, 2022 | -97,647.00 |
| Dec 31, 2021 | -55,292.00 |
| Sep 30, 2021 | 248,693.00 |
| Jun 30, 2021 | 104,858.00 |
| Mar 31, 2021 | -318,382.00 |